High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children

Anesthesiology

Volumn 85, Issue 5, 1996, Pages 965-976

  Journois, Didier ^a   Israel Biet, Dominique ^a   Pouard, Philippe ^a   Rolland, Bénédicte ^a   Silvester, William ^b   Vouhé, Pascal ^a   Safran, Denis ^a  

^a Hopital Laennec   (France)

^b Austin Pathology   (Australia)

Author keywords

Alfentanil blood ; Cardiopulmonary bypass; Cytokines: interleukin 8; interleukin 6 interleukin 1; tumor necrosis factor; complement 3a; Leukocytes: macrophages; monocytes; Midazolam administration and dosage ); Pediatric cardiac: hemofiltration; ultrafiltration

Indexed keywords

ALFENTANIL; MIDAZOLAM;

ARTICLE; BLOOD FILTRATION; CARDIOPULMONARY BYPASS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT BLOOD LEVEL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEMOFILTRATION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG ALVEOLUS OXYGEN TENSION; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ULTRAFILTRATION;

ANESTHETICS; CARDIOPULMONARY BYPASS; CHILD; COMPLEMENT ACTIVATION; CYTOKINES; HEMOFILTRATION; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; INTERLEUKIN-10;

EID: 0029861275     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199611000-00003     Document Type: Article

References (45)

1. Andreasson S, Göthberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B: Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 1993; 56:1515-7
2. Elliott MJ: Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993; 56:1518-22
3. Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhé P, Safran D: Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery: Effects on hemostasis, cytokines and complement components. ANESTHESIOLOGY 1994; 81:1181-9
4. Millar AB, Armstrong L, van der Linden J, Moat N, Ekroth R, Westwick J, Scallan M, Lincoln C: Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993; 56:1499-1502
5. Casey WE, Hauser GJ, Hannallah RS, Midgley FM, Khan WN: Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 1992; 20:1090-6
6. Casey LC: Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993; 56:92-6
7. Naik SK, Knight A, Elliott M: A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation 1991; 84:422-31
8. Naik SK, Balaji S, Elliott MJ: Modified ultrafiltration improves hemodynamics after cardiopulmonary bypass in children. J Am Coll Cardiol 1992; 19:37A
9. Stein B, Pfenninger E, Grunert A, Schmitz JE, Deller A, Kocher F: The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model. Intensive Care Med 1991; 17:293-8
10. Gomez A, Wang R, Unruh H, Light RB, Bose D, Chau T, Correa E, Mink S: Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. ANESTHESIOLOGY 1990; 73:671-85
11. Stein B, Pfenninger E, Grunert A, Schmitz JE, Hudde M: Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990; 16:494-9
12. Lonnemann G, Schindler R, Dinarello CA, Koch KM: Removal of circulating cytokines by hemodialysis membranes in vitro, Host Defense Dysfunction in Trauma, Shock, and Sepsis: Mechanisms and Therapeutic Approaches. Edited by Faist E, Meakins JL, Schildberg FW. Berlin, Springer-Verlag, 1993, pp 613-23
13. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M: Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105:234-41
14. Keber D: On the use of different correction factors for hemoconcentration. Thromb Haemost 1983; 49:245
15. Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-6
16. Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B: Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg 1993; 105:15-24
17. Fosse E, Moen O, Johnson E, Semb G, Brockmeir V, Mollness TE, Fagerhol MK, Venge P: Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994; 58:472-7
18. Hashimoto Y, Hirohata S, Kashiwado T, Itoh K, Ishii H: Cytokine regulation of hemostatic property and IL-6 production of human endothelial cells. Inflammation 1992; 16:613-21
19. van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Buller HR: Elimination of interleukin-6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179:1253-9
20. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Buller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93:114-20
21. Dinarello CA: Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int Suppl 1992; 38:S68-77
22. Strijbos PJ, Hardwick AJ, Relton JK, Carey F, Rothwell NJ: Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF. Am J Physiol 1992; 263:E632-6
23. Gillinov AM, Redmond JM, Winkelstein JA, Zehr KJ, Herskowitz A, Baumgartner WA, Cameron DE: Complement and neutrophil activation during cardiopulmonary bypass: A study in the complement-deficient dog. Ann Thorac Surg 1994; 57:345-52
24. Pascual M, Schifferli JA: Adsorption of complement factor D by polyacrylonitrile dialysis membranes. Kidney Int 1993; 43:903-11
25. Mulvihill J, Cazenave JP, Mazzucotelli JP, Crost T, Collier C, Renaux JL, Pusineri C: Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: Comparison of acrylonitrile copolymer, cuprophan and polysulphone hollow fibres. Biomaterials 1992; 13:527-36
26. Schetz M: Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration. Crit Care Med 1994; 22:715-6
27. Schindler R, Linnenweber S, Schulze M, Oppermann M, Dinarello CA, Shaldon S, Koch KM: Gene expression of interleukin-1 beta during hemodialysis. Kidney Int 1993; 43:712-21
28. Haeffner-Cavaillon N, Roussellier N, Ponzio O, Carreno MP, Laude M, Carpentier A, Kazatchkine MD: Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 98:1100-6
29. Huber AR, Kunkel SL, Todd RF, Weiss SJ: Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991; 254:99-102
30. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ: Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993; 268:12247-9
31. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20
32. Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by interleukin-10. J Exp Med 1991; 174:1549-55
33. Marchant A, Deviere J, Byl B, De Groote D, Vincent JL, Goldman M: Interleukin-10 production during septicaemia. Lancet 1994; 343:707-8
34. Hisatomi K, Isomura T, Kawara T, Yamashita M, Hirano A, Yoshida H, Eriguchi N, Kosuga K, Ohishi K: Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations. J Thorac Cardiovasc Surg 1989; 98:580-91
35. van Oeveren W, Kazatchkine MD, Descamps-Latscha B, Maillet F, Fischer E, Carpentier A, Wildevuur CR: Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985; 89:888-99
36. Howard RJ, Crain C, Franzini DA, Hood CI, Hugli TE: Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg 1988; 123:496-501
37. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW: Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304:497-503
38. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW: Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986; 251:H314-23
39. Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmid- Schonbein GW: Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol 1986; 251:H93-100
40. Davies GG, Wells DG, Mabee TM, Sadler R, Melling NJ: Plateletleukocyte plasmapheresis attenuates the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg 1992; 53:274-7
41. Quiroga MM, Miyagishima R, Haendschen LC, Glovsky M, Martin BA, Hogg JC: The effect of body temperature on leukocyte kinetics during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985; 90:91-6
42. Royston D, Fleming JS, Desai JB, Westaby S, Taylor KM: Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation. J Thorac Cardiovasc Surg 1986; 91:759-66
43. Ratliff NB, Young W Jr, Hackel DB, Mikat E, Wilson JW: Pulmonary injury secondary to extracorporeal circulation. An ultrastructural study. J Thorac Cardiovasc Surg 1973; 65:425-32
44. den Hollander JM, Hennis PJ, Burm AG, Vletter AA, Bovill JG: Pharmacokinetics of alfentanil before and after cardiopulmonary bypass in pediatric patients undergoing cardiac surgery: Part I. J Cardiothorac Vasc Anesth 1992; 6:308-12
45. Hynynen M, Hynninen M, Soini H, Neuvonen PJ, Heinonen J: Plasma concentration and protein binding of alfentanil during high-dose infusion for cardiac surgery. Br J Anaesth 1994; 72:571-6